Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Analysis of heterozygous PRKN variants and copy number variations in Parkinson’s disease

View ORCID ProfileEric Yu, View ORCID ProfileUladzislau Rudakou, View ORCID ProfileLynne Krohn, View ORCID ProfileKheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh, Mehrdad A. Estiar, Dan Spiegelman, Matthew Surface, Stanley Fahn, Cheryl H. Waters, Lior Greenbaum, Alberto J. Espay, Yves Dauvilliers, View ORCID ProfileNicolas Dupré, View ORCID ProfileGuy A. Rouleau, View ORCID ProfileSharon Hassin-Baer, View ORCID ProfileEdward A. Fon, View ORCID ProfileRoy N. Alcalay, View ORCID ProfileZiv Gan-Or
doi: https://doi.org/10.1101/2020.05.07.20072728
Eric Yu
1Department of Human Genetics, McGill University, Montreal, Quebec, Canada
2Montréal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric Yu
Uladzislau Rudakou
1Department of Human Genetics, McGill University, Montreal, Quebec, Canada
2Montréal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Uladzislau Rudakou
Lynne Krohn
1Department of Human Genetics, McGill University, Montreal, Quebec, Canada
2Montréal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lynne Krohn
Kheireddin Mufti
1Department of Human Genetics, McGill University, Montreal, Quebec, Canada
2Montréal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada
BPharm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kheireddin Mufti
Jennifer A. Ruskey
2Montréal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farnaz Asayesh
2Montréal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehrdad A. Estiar
1Department of Human Genetics, McGill University, Montreal, Quebec, Canada
2Montréal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Spiegelman
2Montréal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Surface
4Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY 10032, USA
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanley Fahn
4Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY 10032, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl H. Waters
4Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY 10032, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lior Greenbaum
5The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
6The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
7Sackler school of medicine, Tel-Aviv University, Tel-Aviv, Israel
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto J. Espay
8UC Gardner Neuroscience Institute and Gardner Family Center for Parkinson’s Disease and Movement Disorders, Cincinnati, OH, USA
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yves Dauvilliers
9National Reference Center for Narcolepsy, Sleep Unit, Department of Neurology, Guide-Chauliac Hospital, CHU Montpellier, University of Montpellier, Inserm U1061, Montpellier, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Dupré
10Division of Neurosciences, CHU de Québec, Université Laval, Québec City, Quebec, Canada
11Department of Medicine, Faculty of Medicine, Université Laval, Québec City, Quebec, Canada
MD, FRCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicolas Dupré
Guy A. Rouleau
1Department of Human Genetics, McGill University, Montreal, Quebec, Canada
2Montréal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada
MD, PhD, FRCPC, FRSC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guy A. Rouleau
Sharon Hassin-Baer
7Sackler school of medicine, Tel-Aviv University, Tel-Aviv, Israel
12Movement Disorders Institute, Department of Neurology, Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sharon Hassin-Baer
Edward A. Fon
2Montréal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada
MD, FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edward A. Fon
Roy N. Alcalay
4Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY 10032, USA
13Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Roy N. Alcalay
Ziv Gan-Or
1Department of Human Genetics, McGill University, Montreal, Quebec, Canada
2Montréal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ziv Gan-Or
  • For correspondence: ziv.gan-or{at}mcgill.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Biallelic PRKN mutation carriers with Parkinson’s disease (PD) typically have an earlier disease onset, slow disease progression and, often, different neuropathology compared to sporadic PD patients. However, the role of heterozygous PRKN variants in the risk of PD is controversial.

Objectives We aimed to examine the association between heterozygous PRKN variants, including single nucleotide variants and copy-number variations, and PD.

Methods We fully sequenced PRKN in 2,809 PD patients and 3,629 healthy controls, including 1,965 late onset (63.97±7.79 years, 63% men) and 553 early onset PD patients (43.33±6.59 years, 68% men). PRKN was sequenced using targeted next-generation sequencing with molecular inversion probes. Copy-number variations were identified using a combination of multiplex ligation-dependent probe amplification and ExomeDepth. To examine whether rare heterozygous single nucleotide variants and copy-number variations in PRKN are associated with PD risk and onset, we used optimized sequence kernel association tests and regression models.

Results We did not find any associations between all types of PRKN variants and risk of PD. Pathogenic and likely-pathogenic heterozygous single nucleotide variants and copy-number variations were less common among PD patients (1.52%) than among controls (1.8%, false discovery rate-corrected p=0.55). No associations with age at onset and in stratified analyses were found.

Conclusions Heterozygous single nucleotide variants and copy-number variations in PRKN are not associated with Parkinson’s disease. Molecular inversion probes allow for rapid and cost-effective detection of all types of PRKN variants, which may be useful for pre-trial screening and for clinical and basic science studies specifically targeting PRKN patients.

Competing Interest Statement

Dr. Fahn received consulting fees/honoraria for board membership from Retrophin Inc., Sun Pharma Advanced Research Co., LTD and Kashiv Pharma. Dr. Waters received research support from Sanofi, Biogen, Roche, consulting fees/honoraria from Amneal, Adamas, Impel, Kyowa, Mitsubishi, Neurocrine, US World Meds, Acadia, Acorda. Dr. Espay received grant support from the NIH and the Michael J Fox Foundation; personal compensation as a consultant/scientific advisory board member for Abbvie, Adamas, Acadia, Acorda, Neuroderm, Neurocrine, Impax/Amneal, Sunovion, Lundbeck, Osmotica Pharmaceutical, and US World Meds; publishing royalties from Lippincott Williams & Wilkins, Cambridge University Press, and Springer; and honoraria from US World Meds, Lundbeck, Acadia, Sunovion, the American Academy of Neurology, and the Movement Disorders Society. Dr. Dupré received consultancy fees from Actelion Pharmaceuticals. Dr. Hassin-Baer received consulting fees from Actelion Pharmaceuticals Ltd., Abbvie Israel, Robotico Ltd., Medtronic Israel, Medison Pharma Israel. Dr. Fon received consulting fees from Inception Sciences. Dr. Alcalay received consultation fees from Biogen, Denali, Genzyme/Sanofi and Roche. Dr. Gan-Or received consultancy fees from Lysosomal Therapeutics Inc. (LTI), Idorsia, Prevail Therapeutics, Inceptions Sciences (now Ventus), Ono Therapeutics, Denali and Deerfield. No other disclosures were reported.

Funding Statement

Funding/Support

This work was financially supported by grants from the Michael J. Fox Foundation, the Canadian Consortium on Neurodegeneration in Aging (CCNA), the Canada First Research Excellence Fund (CFREF), awarded to McGill University for the Healthy Brains for Healthy Lives initiative (HBHL), and Parkinson Canada. The Columbia University cohort is supported by the Parkinson’s Foundation, the National Institutes of Health (K02NS080915, and UL1 TR000040) and the Brookdale Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Study protocols were approved by the relevant Institutional Review Boards and all patients signed informed consent before participating in the study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted August 20, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Analysis of heterozygous PRKN variants and copy number variations in Parkinson’s disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Analysis of heterozygous PRKN variants and copy number variations in Parkinson’s disease
Eric Yu, Uladzislau Rudakou, Lynne Krohn, Kheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh, Mehrdad A. Estiar, Dan Spiegelman, Matthew Surface, Stanley Fahn, Cheryl H. Waters, Lior Greenbaum, Alberto J. Espay, Yves Dauvilliers, Nicolas Dupré, Guy A. Rouleau, Sharon Hassin-Baer, Edward A. Fon, Roy N. Alcalay, Ziv Gan-Or
medRxiv 2020.05.07.20072728; doi: https://doi.org/10.1101/2020.05.07.20072728
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Analysis of heterozygous PRKN variants and copy number variations in Parkinson’s disease
Eric Yu, Uladzislau Rudakou, Lynne Krohn, Kheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh, Mehrdad A. Estiar, Dan Spiegelman, Matthew Surface, Stanley Fahn, Cheryl H. Waters, Lior Greenbaum, Alberto J. Espay, Yves Dauvilliers, Nicolas Dupré, Guy A. Rouleau, Sharon Hassin-Baer, Edward A. Fon, Roy N. Alcalay, Ziv Gan-Or
medRxiv 2020.05.07.20072728; doi: https://doi.org/10.1101/2020.05.07.20072728

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3292)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13374)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14627)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)